Macrophage migration inhibitory factor (MIF) in bullous pemphigoid

Journal of Dermatological Science

Volumn 49, Issue 1, 2008, Pages 95-97

  Asano, Yukie ^a   Makino, Teruhiko ^a   Norisugi, Osamu ^a   Watanabe, Hirokazu ^a   Abe, Riichiro ^b   Shimizu, Hiroshi ^b   Shimizu, Tadamichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; AGED; BULLOUS PEMPHIGOID; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKIN BIOPSY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLISTER; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MIDDLE AGED; PEMPHIGOID, BULLOUS; SKIN;

EID: 36849063852     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2007.09.011     Document Type: Letter

References (10)

1. Calanda T., Bernhagen J., Mitchell R.A., and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179 (1994) 1895-1902
2. Nakamaru Y., Oridate N., Nishihira J., Takagi D., Furuta Y., and Fukuda S. Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis. Cytokine 31 (2005) 103-108
3. Shimizu T. Role of macrophage migration inhibitory factor (MIF) in the skin. J Dermatol Sci 37 (2005) 65-73
4. Rossi A.G., Haslett C., Hirani N., Greening A.P., Rahman I., Metz C.N., et al. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma. J Clin Invest 101 (1998) 2869-2874
5. Shimizu T., Nishihira J., Mizue Y., Nakamura H., Abe R., Watanabe H., et al. High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis. J Invest Dermatol 116 (2001) 989-990
6. Shimizu T., Abe R., Ohkawara A., Mizue Y., and Nishihira J. Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem Biophys Res Commun 240 (1997) 173-178
7. Schmidt E., Bastian B., Dummer R., Tony H., Brocker E., and Zillikens D. Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid. Arch Dermatol Res 288 (1996) 353-357
8. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., et al. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3 (1997) 272-273
9. Saeki H., and Tamaki K. Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases. J Dermatol Sci 43 (2006) 75-84
10. Frezzolini A., Teofoli P., Cianchini G., Barduagni S., Ruffelli M., Ferranti G., et al. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol 12 (2002) 27-31